Immuneering Corp (IMRX)
1.56
-0.09
(-5.45%)
USD |
NASDAQ |
May 07, 16:00
1.56
0.00 (0.00%)
After-Hours: 20:00
Immuneering Cash from Operations (Quarterly): -11.78M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.78M |
| September 30, 2023 | -12.03M |
| June 30, 2023 | -10.75M |
| March 31, 2023 | -14.42M |
| December 31, 2022 | -11.75M |
| September 30, 2022 | -10.62M |
| June 30, 2022 | -9.449M |
| March 31, 2022 | -12.28M |
| Date | Value |
|---|---|
| December 31, 2021 | -9.239M |
| September 30, 2021 | -9.035M |
| June 30, 2021 | -6.437M |
| March 31, 2021 | -6.140M |
| December 31, 2020 | -5.453M |
| September 30, 2020 | -3.486M |
| June 30, 2020 | -3.367M |
| March 31, 2020 | -2.314M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-14.42M
Minimum
Mar 2023
-2.314M
Maximum
Mar 2020
-8.659M
Average
-9.344M
Median
Cash from Operations (Quarterly) Benchmarks
| Geron Corp | -62.25M |
| SELLAS Life Sciences Group Inc | -4.825M |
| Elicio Therapeutics Inc | -- |
| Vistagen Therapeutics Inc | -4.535M |
| ADMA Biologics Inc | 17.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 3.133M |
| Cash from Financing (Quarterly) | 0.0078M |
| Free Cash Flow | -49.31M |
| Free Cash Flow Per Share (Quarterly) | -0.408 |
| Free Cash Flow Yield | -111.3% |